论文部分内容阅读
目的研究垂体后叶素、米索前列醇联合缩宫素治疗产后出血的临床治疗效果。方法选取100例产后出血的孕产妇,将其分为对照组与观察组,对照组应用缩宫素单一治疗,观察组应用垂体后叶素、米索前列醇联合缩宫素治疗。对比产后出血量及治疗效果并进行临床治疗分析。结果垂体后叶素、米索前列醇联合缩宫素治疗方法的出血量明显少于单一治疗法,治疗效果明显优于单一治疗法,这是一种有效的治疗孕产妇产后出血症状的方法。结论垂体后叶素、米索前列醇联合缩宫素治疗法不能作用于心脏器官出现问题及妊高征、脑部血管受损、癫痫病的患者等,该治疗方法有人群限制,然而总体来说,这种治疗方法花费的成本少、操作简便,是一种非常值得推广的产后出血治疗方案。
Objective To study the clinical effect of pituitrin and misoprostol combined with oxytocin in the treatment of postpartum hemorrhage. Methods 100 pregnant women with postpartum hemorrhage were selected and divided into the control group and the observation group. The control group was treated with oxytocin single therapy. The observation group was treated with pituitrin and misoprostol combined with oxytocin. Postpartum hemorrhage and treatment efficacy and clinical analysis. Results The amount of bleeding of pituitrin and misoprostol combined with oxytocin was significantly less than that of single therapy and the treatment effect was superior to that of single therapy, which was an effective method of treating postpartum hemorrhage. Conclusions Pituitrin and misoprostol combined with oxytocin therapy can not be used in patients with cardiac organ problems and PIH, impaired cerebral blood vessels, and epilepsy. However, the treatment method has crowd restriction. However, in general, Said that this treatment costs less, easy to operate, is a very worthy of promotion of postpartum hemorrhage treatment.